tradingkey.logo

Cryoport Inc

CYRX
10.560USD
+0.060+0.57%
收盤 01/09, 16:00美東報價延遲15分鐘
528.73M總市值
8.38本益比TTM

Cryoport Inc

10.560
+0.060+0.57%

關於 Cryoport Inc 公司

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Cryoport Inc簡介

公司代碼CYRX
公司名稱Cryoport Inc
上市日期Jul 24, 2015
CEOShelton (Jerrell Wilson)
員工數量1090
證券類型Ordinary Share
年結日Jul 24
公司地址112 Westwood Place, Suite 350
城市BRENTWOOD
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編37027
電話19492321900
網址https://www.cryoport.com/
公司代碼CYRX
上市日期Jul 24, 2015
CEOShelton (Jerrell Wilson)

Cryoport Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+25000.00%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+23214.00%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+23214.00%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+25000.00%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+25000.00%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+23214.00%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+23214.00%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+25000.00%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Life Science products
19.98M
45.16%
BioLogistics solutions
19.43M
43.92%
BioStorage/Bioservices
4.83M
10.92%
地區USD
名稱
營收
佔比
Americas
33.14M
74.93%
Europe & Middle East & Africa (EMEA)
6.63M
15.00%
Asia Pacific
4.46M
10.07%
業務
地區
業務USD
名稱
營收
佔比
Life Science products
19.98M
45.16%
BioLogistics solutions
19.43M
43.92%
BioStorage/Bioservices
4.83M
10.92%

股東統計

更新時間: 1月2日 週五
更新時間: 1月2日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
其他
63.25%
持股股東
持股股東
佔比
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
其他
63.25%
股東類型
持股股東
佔比
Investment Advisor
41.65%
Investment Advisor/Hedge Fund
25.48%
Hedge Fund
22.33%
Research Firm
11.05%
Individual Investor
3.99%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.43%
Pension Fund
0.42%
Family Office
0.10%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
367
51.10M
102.06%
-7.68M
2025Q3
382
51.46M
118.49%
+897.37K
2025Q2
395
50.60M
125.22%
-144.83K
2025Q1
397
50.53M
128.31%
-13.51M
2024Q4
394
50.41M
130.61%
-180.77K
2024Q3
409
50.54M
130.03%
-5.26M
2024Q2
410
52.11M
125.57%
-2.50M
2024Q1
424
53.98M
124.33%
-7.14M
2023Q4
457
52.70M
119.71%
+4.70M
2023Q3
471
48.09M
113.05%
-102.80K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Cadian Capital Management LP
4.98M
9.95%
+14.84K
+0.30%
Sep 30, 2025
Morgan Stanley & Co. LLC
4.56M
9.11%
+12.81K
+0.28%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.38M
6.74%
-29.89K
-0.88%
Sep 30, 2025
The Vanguard Group, Inc.
2.86M
5.71%
+69.55K
+2.49%
Sep 30, 2025
Brown Capital Management, LLC
2.62M
5.24%
-1.18M
-30.99%
Sep 30, 2025
Millennium Management LLC
2.62M
5.23%
+408.33K
+18.46%
Sep 30, 2025
Fred Alger Management, LLC
1.78M
3.56%
-578.45K
-24.52%
Sep 30, 2025
Thematics Asset Management SAS
1.66M
3.32%
+1.04M
+168.96%
Mar 31, 2025
Natixis Investment Managers SA
1.64M
3.27%
-276.26K
-14.43%
Sep 30, 2025
Assenagon Asset Management S.A.
1.50M
2.99%
+408.26K
+37.44%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.56%
Inspire Small/Mid Cap ESG ETF
0.21%
JPMorgan Fundamental Data Science Small Core ETF
0.1%
Avantis US Small Cap Equity ETF
0.05%
Vanguard US Momentum Factor ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.56%
Inspire Small/Mid Cap ESG ETF
佔比0.21%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.1%
Avantis US Small Cap Equity ETF
佔比0.05%
Vanguard US Momentum Factor ETF
佔比0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
Global X Russell 2000 ETF
佔比0.02%
ProShares UltraPro Russell2000
佔比0.02%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.02%
ProShares Hedge Replication ETF
佔比0.02%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Cryoport Inc的前五大股東是誰?

Cryoport Inc的前五大股東如下:
Cadian Capital Management LP
持有股份:4.98M
佔總股份比例:9.95%。
Morgan Stanley & Co. LLC
持有股份:4.56M
佔總股份比例:9.11%。
BlackRock Institutional Trust Company, N.A.
持有股份:3.38M
佔總股份比例:6.74%。
The Vanguard Group, Inc.
持有股份:2.86M
佔總股份比例:5.71%。
Brown Capital Management, LLC
持有股份:2.62M
佔總股份比例:5.24%。

Cryoport Inc的前三大股東類型是什麼?

Cryoport Inc 的前三大股東類型分別是:
Cadian Capital Management LP
Morgan Stanley & Co. LLC
BlackRock Institutional Trust Company, N.A.

有多少機構持有Cryoport Inc(CYRX)的股份?

截至2025Q4,共有367家機構持有Cryoport Inc的股份,合計持有的股份價值約為51.10M,占公司總股份的102.06% 。與2025Q3相比,機構持股有所增加,增幅為-16.43%。

哪個業務部門對Cryoport Inc的收入貢獻最大?

在FY2025Q3,Life Science products業務部門對Cryoport Inc的收入貢獻最大,創收19.98M,占總收入的45.16% 。
KeyAI